RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board
Continue reading »
Home ยป
Non-caloric sweetener reduces signs of fatty liver disease in preclinical research study
There is clear evidence that high sugar consumption leads to obesity and fatty liver disease. Synthetic and natural alternatives to
Continue reading »
Preclinical data shows combination immunotherapy could stop liver cancer growth
Even as overall cancer incidence and mortality decrease in the United States, the number of people diagnosed with liver cancer
Continue reading »